New protein therapy shows promise for Tough-to-Treat inflammation
NCT ID NCT06877364
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study tested a protein called GcMAF in 120 people with chronic inflammatory diseases like rheumatoid arthritis or cystitis that didn't respond to standard treatments. The goal was to see if it is safe and can reduce inflammation. The study had two parts: first, finding a safe dose, then comparing the treatment to a placebo in a blinded fashion.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center For New Medical Technologies
Novosibirsk, Russia
Conditions
Explore the condition pages connected to this study.